MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth

Purpose Prostate cancer (PCa) is characterized by deregulated expression of several tumor suppressor or oncogenic miRNAs. The objective of this study was the identification and characterization of miR-let-7c as a potential tumor suppressor in PCa. Experimental Design Levels of expression of miR-let-7c were examined in human PCa cell lines and tissues using qRT-PCR and in situ hybridization. Let-7c was overexpressed or suppressed to assess the effects on the growth of human PCa cell lines. Lentiviral-mediated re-expression of let-7c was utilized to assess the effects on human PCa xenografts. Results We identified miR-let-7c as a potential tumor suppressor in PCa. Expression of let-7c is downregulated in castration-resistant prostate cancer (CRPC) cells. Overexpression of let-7c decreased while downregulation of let-7c increased cell proliferation, clonogenicity and anchorage-independent growth of PCa cells in vitro. Suppression of let-7c expression enhanced the ability of androgen-sensitive PCa cells to grow in androgen-deprived conditions in vitro. Reconstitution of Let-7c by lentiviral-mediated intratumoral delivery significantly reduced tumor burden in xenografts of human PCa cells. Furthermore, let-7c expression is downregulated in clinical PCa specimens compared to their matched benign tissues, while the expression of Lin28, a master regulator of let-7 miRNA processing, is upregulated in clinical PCa specimens. Conclusions These results demonstrate that microRNA let-7c is downregulated in PCa and functions as a tumor suppressor, and is a potential therapeutic target for PCa.

• Publication year

  2012

• Venue

  PLoS ONE

• Publication date

  2012-03-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0032832PMID 22479342PMCID 3316551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells*

  2011influential reference
• MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2

  2010cited by this paper
• Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer

  2010cited by this paper
• Microrna let-7: an emerging next-generation cancer therapeutic

  2010cited by this paper
• Microarray analysis reveals potential target genes of NF‐κB2/p52 in LNCaP prostate cancer cells

  2010cited by this paper
• MicroRNAs and prostate cancer.

  2010cited by this paper
• Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

  2010cited by this paper
• The role of let-7 in cell differentiation and cancer.

  2010cited by this paper
• Lin28: A microRNA regulator with a macro role.

  2010cited by this paper
• Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor.

  2010cited by this paper
• Lin28 Enhances Tumorigenesis and is Associated With Advanced Human Malignancies

  2009cited by this paper
• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7

  2009cited by this paper
• CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis

  2009cited by this paper
• Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation

  2009cited by this paper
• Towards the definition of prostate cancer-related microRNAs: where are we now?

  2009cited by this paper
• Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3

  2008cited by this paper
• microRNAs and prostate cancer

  2008cited by this paper
• Widespread deregulation of microRNA expression in human prostate cancer

  2008cited by this paper
• Cancerous miRNAs and their regulation

  2008cited by this paper
• Selective Blockade of MicroRNA Processing by Lin28

  2008cited by this paper
• NF‐κB2/p52 enhances androgen‐independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen‐deprivation

  2008cited by this paper
• The let-7 microRNA reduces tumor growth in mouse models of lung cancer

  2008cited by this paper
• Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma

  2008cited by this paper
• MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.

  2007cited by this paper
• Impaired microRNA processing enhances cellular transformation and tumorigenesis

  2007influential reference
• The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

  2007cited by this paper
• Interleukin‐6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression

  2007influential reference
• Let-7 expression defines two differentiation stages of cancer

  2007cited by this paper
• let-7 regulates self renewal and tumorigenicity of breast cancer cells.

  2007cited by this paper
• Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation.

  2006cited by this paper
• Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation

  2006influential reference
• Real-time expression profiling of microRNA precursors in human cancer cell lines

  2005cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• RAS is regulated by the let-7 microRNA family.

  2005cited by this paper
• Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

  2004cited by this paper
• Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

  2004cited by this paper
• Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells.

  2003influential reference
• P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo.

  1996cited by this paper
• Tumorigenesis and Neoplastic Progression A Novel Role of Myosin VI in Human Prostate Cancer

  year unknowncited by this paper

• New Genetic Variations in RNA-binding Protein Gene and Breast Cancer Risk: A Case-Control Study

  2025cites this paper
• Circulating microRNAs as biomarker in prostate cancer and their significance in the differentiation of benign and malignant conditions of the prostate

  2025cites this paper
• MiRNAs and tempol therapeutic potential in prostate cancer: a preclinical approach

  2025cites this paper
• Electrochemiluminescence Biosensor Based on a Self-protected DNAzyme Walker with a Circular Bulging DNA Shield for MicroRNA Detection.

  2025cites this paper
• The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases

  2025cites this paper
• Deciphering the let-7c-5p/RRM2 axis in lung adenocarcinoma: expression, prognosis, and immune landscape implications

  2025cites this paper
• The function and mechanisms of action of non-coding RNAs in prostatic diseases

  2025cites this paper
• Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD).

  2024cites this paper
• Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent

  2024cites this paper
• Analysis of miRNAs in milk of four livestock species

  2024cites this paper
• MicroRNA signature of stromal-epithelial interactions in prostate and breast cancers.

  2024cites this paper
• A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer’s Disease Risk in Older Men with Prostate Cancer

  2024cites this paper
• Melatonin Inhibits ET‐1 Production to Break Crosstalk Between Prostate Cancer and Bone Cells: Implication for Osteoblastic Bone Metastasis Treatment

  2024cites this paper
• Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power.

  2023cites this paper
• A glimpse into let-7e roles in human disorders; friend or foe?

  2023cites this paper
• Developing microRNAs as engineering tools to modulate monoclonal antibody galactosylation

  2023cites this paper
• State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer

  2023cites this paper
• Expression of miRNAs in prostate cancer cell lines and prostate epithelial cell lines

  2023cites this paper
• The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer.

  2023cites this paper
• Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms

  2023cites this paper
• Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review

  2023cites this paper
• MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer

  2023cites this paper
• Role of epigallocatechin-3- gallate in the regulation of known and novel microRNAs in breast carcinoma cells

  2022cites this paper
• Lin28 Regulates Cancer Cell Stemness for Tumour Progression

  2022cites this paper
• Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors

  2022cites this paper
• Plasmonic-Based Biosensor for the Early Diagnosis of Prostate Cancer

  2022cites this paper
• The microRNomes of Chinese Hamster Ovary (CHO) cells and their extracellular vesicles, and how they respond to osmotic and ammonia stress

  2022cites this paper
• Targeting Castration-Resistant Prostate Cancer Using Mesenchymal Stem Cell Exosomes for Therapeutic MicroRNA-let-7c Delivery.

  2022cites this paper
• The Regulation of let-7c-5p on the Biological Characteristics of Lung Adenocarcinoma Cells by Targeting AURKB

  2022cites this paper
• Tumor-promoting roles of HMMR in lung adenocarcinoma.

  2022cites this paper
• Effects of let-7a microRNA and C–C chemokine receptor type 7 expression on cellular function and prognosis in esophageal squamous cell carcinoma

  2022cites this paper
• MicroRNA Associated with the Invasive Phenotype in Clear Cell Renal Cell Carcinoma: Let-7c-5p Inhibits Proliferation, Migration, and Invasion by Targeting Insulin-like Growth Factor 1 Receptor

  2022cites this paper
• The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness

  2021cites this paper
• Modulation of noncoding RNAs (ncRNAs) and their potential role as therapeutics

  2021cites this paper
• Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition.

  2021cites this paper
• miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools

  2021cites this paper
• Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma

  2021cites this paper
• Genetic meta-analysis of cancer diagnosis following statin use identifies new associations and implicates human leukocyte antigen (HLA) in women

  2021cites this paper
• Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance

  2021cites this paper
• miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer

  2021cites this paper
• Identification of important extracellular vesicle RNA molecules related to sperm motility and prostate cancer

  2021cites this paper
• Slow transcription of the 99a/let-7c/125b-2 cluster results in differential miRNA expression and promotes melanoma phenotypic plasticity.

  2021cites this paper
• Targeting LIN28: a new hope in prostate cancer theranostics.

  2021cites this paper
• [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].

  2021cites this paper
• miRNAs and androgen deprivation therapy for prostate cancer.

  2021cites this paper
• Profiles of microRNA in aqueous humor of normal tension glaucoma patients using RNA sequencing

  2021cites this paper
• Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs

  2021cites this paper
• Emerging role of let-7 family in the pathogenesis of hematological malignancies.

  2021cites this paper
• Extracellular Vesicles-Mediated Transfer of miRNA Let-7b from PC3 Cells to Macrophages

  2020cites this paper
• Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells

  2020cites this paper
• The oncogenic function of PLAGL2 is mediated via specific target genes through a Wnt-independent mechanism in colorectal cancer

  2020cites this paper
• Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers

  2020cites this paper
• Hsa-let-7c exerts an anti-tumor function by negatively regulating ANP32E in lung adenocarcinoma.

  2020cites this paper
• Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study

  2020cites this paper
• Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify SOX13 to Be Involved in Invasion and Progression of Pancreatic Cancer

  2020cites this paper
• Use of miRNA as a Biomarker in Prostate Cancer and New Approaches

  2020cites this paper
• Multifaceted Function of MicroRNA-299-3p Fosters an Antitumor Environment Through Modulation of Androgen Receptor and VEGFA Signaling Pathways in Prostate Cancer

  2020cites this paper
• Retracted: MicroRNA let‐7b Inhibits Proliferation and Induces Apoptosis of Castration‐Resistant Prostate Cancer Cells by Blocking the Ras/Rho Signaling Pathway via NRAS

  2020cites this paper
• Role of androgen and microRNA in triple-negative breast cancer

  2019cites this paper
• miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma

  2019cites this paper
• Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer

  2019cites this paper
• Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer

  2019influential citation
• Exploring the Potential of MicroRNA Let-7c as a Therapeutic for Prostate Cancer

  2019influential citation
• Genetic polymorphisms of PPAR genes and human cancers: evidence for gene–environment interactions

  2019cites this paper
• Bioinformatics Resource Manager: a systems biology web tool for microRNA and omics data integration

  2019cites this paper
• Exploring the tissue tropism of pseudorabies virus based on miRNA level analysis

  2019cites this paper
• The Influence of microRNAs in Regulation of Hormone Dependence in Prostate Cancer Cells

  2019cites this paper
• Cancer The 'RBP'eutics - RNA-Binding Proteins as Therapeutic Targets for Cancer.

  2019cites this paper
• The Prostate

  2019cites this paper
• MicroRNA‐let‐7c suppresses hepatitis C virus replication by targeting Bach1 for induction of haem oxygenase‐1 expression

  2019cites this paper
• MicroRNAs: Key Players in Bladder Cancer

  2019cites this paper
• Kinetics of the chromosome 14 microRNA cluster ortholog and its potential role during placental development in the pregnant mare

  2018cites this paper
• Let-7c inhibits migration and epithelial–mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2

  2018cites this paper
• Associations of glycated hemoglobin (HbA1c) level with central corneal and macular thickness in diabetic patients without macular edema

  2018cites this paper
• MiR-33a and statins collaboratively reduce the proliferative capacity of prostate cancer cells

  2018cites this paper
• Let-7c Inhibits the Proliferation, Invasion, and Migration of Glioma Cells via Targeting E2F5.

  2018cites this paper
• Antiproliferative effect of upregulation of hsa-let-7c-5p in human acute erythroleukemia cells

  2018cites this paper
• Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1/S phase arrest.

  2018cites this paper
• The role of microRNAs in prostate cancer migration, invasion, and metastasis

  2018cites this paper
• Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma

  2018cites this paper
• Implications of microRNA dysregulation in the development of prostate cancer.

  2017cites this paper
• The Role of Noncoding RNAs in Prostate Cancer

  2017cites this paper
• Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway

  2017cites this paper
• Tissue control of androgen action: The ups and downs of androgen receptor expression.

  2017cites this paper
• Androgen receptor/let-7a signaling regulates breast tumor-initiating cells

  2017cites this paper
• Exosomal and Non‐Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis

  2017cites this paper
• Hsa-let-7c-5p augments enterovirus 71 replication through viral subversion of cell signaling in rhabdomyosarcoma cells

  2017cites this paper
• A step-by-step microRNA guide to cancer development and metastasis

  2017cites this paper
• The Effect of Newly Synthesized Heterosteroids on miRNA34a, 98, and 214 Expression Levels in MCF-7 Breast Cancer Cells

  2017cites this paper
• Resveratrol and pterostilbene as a microRNA‐mediated chemopreventive and therapeutic strategy in prostate cancer

  2017cites this paper
• Anti-inflammatory role of microRNA let-7c in LPS treated alveolar macrophages by targeting STAT3.

  2016cites this paper
• Molecular mechanisms and microRNAs in osteosarcoma pathogenesis

  2016cites this paper
• JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells

  2016cites this paper
• MicroRNAs and epithelial-mesenchymal transition in prostate cancer

  2016cites this paper
• A novel oncogenic axis involving the ETS factor ESE3/EHF, miR-424, COP1 and STAT3 drives prostate tumor progression

  2016cites this paper
• Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1

  2016cites this paper
• Lin28 induces resistance to anti‐androgens via promotion of AR splice variant generation

  2016cites this paper
• Lin28: an emerging important oncogene connecting several aspects of cancer

  2016cites this paper
• Circulating MicroRNAs as Non-invasive Molecular Biomarkers for Early Detection Breast cancer

  2016cites this paper
• Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role

  2016cites this paper